JNCI-Journal of the National Cancer Institute

Article	Citations
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group	315
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics	274
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study	171
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy	161
Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis	138
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis	122
“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials	117
State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States	112
Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care	110
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer	108
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial	99
Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care	97
Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma	96
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling	94
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer	83
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer	81
Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening	81
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults	79
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report	77
Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening	77
Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines	74
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers	73
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis	72
Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States	71
Changes in Mammography Use by Women’s Characteristics During the First 5 Months of the COVID-19 Pandemic	70

Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services	68
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study	66
Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer	64
Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts	63
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial	62
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States	61
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis	58
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer	58
Germline Cancer Predisposition Variants in  Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group	57
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer	57
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients	56
Evidence Gaps in Cancer Survivorship Care: A Report From the 2019 National Cancer Institute Cancer Survivorship Workshop	55
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy	54
All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort	53
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research	51
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion	50
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients	50
Performance of Digital Breast Tomosynthesis, Synthetic Mammography, and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis	50
A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma	50
Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis	48
Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap	47
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group	47
Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests	47
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer	47
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy	47
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation	47
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women	46
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database	45
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study	44
The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States	42
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk	42
Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry	41
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue	41
Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting Report	40
Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States	40
Epigenetic Age Acceleration and Chronic Health Conditions Among Adult Survivors of Childhood Cancer	39
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women	39
The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities	39
Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer	38
Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis	38
Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer	38
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes	37
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy	36
Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers	35
Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research	35
Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017	35
Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study	35
Targeted eHealth Intervention to Reduce Breast Cancer Survivors’ Fear of Recurrence: Results From the FoRtitude Randomized Trial	34
Disparities in Cancer Survival Among Adolescents and Young Adults: A Population-Based Study of 88 000 Patients	34
Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges	34

KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis	34
Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study	33
Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History	33
Breast Cancer Screening Trials: Endpoints and Overdiagnosis	33
Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study	33
Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma	32
Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study	32
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925	32
Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis	32
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute	31
BRCA1Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis	31
Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed	30
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications	29
Association of Medical Financial Hardship and Mortality Among Cancer Survivors in the United States	29
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies	28
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV	28
Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer	28
Smoking Cessation Prevalence and Inequalities in the United States: 2014-2019	28
Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130	28
The Role of Mendelian Randomization Studies in Deciphering the Effect of Obesity on Cancer	27
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer	27
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients	27
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer	27
Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker	27
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer	27
Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening	26
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials	26
Temporal Trends in Opioid Prescribing Patterns Among Oncologists in the Medicare Population	25
An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study	25
NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis	25
Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study	25
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial	25
Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study	25
Timing of Aspirin Use in Colorectal Cancer Chemoprevention: A Prospective Cohort Study	24
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review	24
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405	24
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy	24
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review	24
Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females	24
Readdressing the Needs of Cancer Survivors During COVID-19: A Path Forward	24
Racial Disparities in Recurrence and Overall Survival in Patients With Locoregional Colorectal Cancer	24
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32	23
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma	23
Use of Straighteners and Other Hair Products and Incident Uterine Cancer	23
Early Medicaid Expansion and Cancer Mortality	23
Cost-Effectiveness of Nasopharyngeal Carcinoma Screening With Epstein-Barr Virus Polymerase Chain Reaction or Serology in High-Incidence Populations Worldwide	23
The Anatomy and Physiology of Teaming in Cancer Care Delivery: A Conceptual Framework	23
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy	22
Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018	22
Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study	22
Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population	22
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database	22
Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer	22
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis	22
The Impact of Breast Density Information or Notification on Women’s Cognitive, Psychological, and Behavioral Outcomes: A Systematic Review	22
Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline	22
Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium	22
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040	22
Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis	21
The Oral Microbiome and Lung Cancer Risk: An Analysis of 3 Prospective Cohort Studies	21
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium	21
Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer	21
Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials	21
Multicancer Early Detection: Learning From the Past to Meet the Future	21
Association Between Medicaid Expansion Under the Affordable Care Act and Survival Among Newly Diagnosed Cancer Patients	21
Racial Disparities in Epigenetic Aging of the Right vs Left Colon	21
Performance of Breast Cancer Polygenic Risk Scores in 760 FemaleCHEK2Germline Mutation Carriers	20
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer	20
Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals’ Risk Profiles	20
BRAFV600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database	20
Employment Outcomes Among Cancer Survivors in the United States: Implications for Cancer Care Delivery	20
Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma	19
Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status	19
Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis	19
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer	19
Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study	19
Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores	18
Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study	18
Essentialism and Exclusion: Racism in Cancer Risk Prediction Models	18
21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma In Situ	18

Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer	18
Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report	18
Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality	18
Addressing Transportation Insecurity Among Patients With Cancer	18
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective	18
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features	17
Grade Migration of Prostate Cancer in the United States During the Last Decade	17
Summary From the First Kidney Cancer Research Summit, September 12–13, 2019: A Focus on Translational Research	17
Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer	17
Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report	16
Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates	16
Trends in the incidence of young-onset colorectal cancer with a focus on years approaching screening age: A population-based longitudinal study	16
Cancer Incidence in World Trade Center Rescue and Recovery Workers: 14 Years of Follow-Up	16
Overcoming the challenges to implementation of artificial intelligence in pathology	16
A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting	16
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials	16
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma	16
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer	16
Effect of the p53 P72R Polymorphism on MutantTP53Allele Selection in Human Cancer	16
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies	16
Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma	16
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds	16
Study design considerations for trials to evaluate multicancer early detection assays for clinical utility	16
Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology	16
Housing and Cancer Care and Outcomes: A Systematic Review	15
Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study	15
Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening	15
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients	15
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas	15
Changes in survival in de novo metastatic cancer in an era of new medicines	15
Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers	15
COVID-19, Social Justice, and Clinical Cancer Research	15
Behavioral Research in Cancer Prevention and Control: Emerging Challenges and Opportunities	15
Housing Insecurity Among Patients With Cancer	15
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment	15
Association ofGATA3Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia	15
Association of Medicaid Expansion With Cancer Stage and Disparities in Newly Diagnosed Young Adults	15
Trends of Cancer-Related Suicide in the United States: 1999-2018	15
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials	14
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry	14
The Global Landscape of Treatment Standards for Breast Cancer	14
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome	14
Patient-Reported Outcomes for Tolerability Assessment in Phase I Cancer Clinical Trials	14
Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study	14
Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001-2015	14
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer	14
Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region	14
A Comparison of Late Mortality Among Survivors of Childhood Cancer in the United States and United Kingdom	14
Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants	14
Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial	14
A Serum Marker for Early Pancreatic Cancer With a Possible Link to Diabetes	13
Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial	13
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical Trials	13
Cancer Hazard Evaluations for Contemporary Needs: Highlights From New National Toxicology Program Evaluations and Methodological Advancements	13
Financial Toxicity in Adolescent and Young Adult Cancer Survivors: Proposed Directions for Future Research	13
Food Insecurity Among People With Cancer: Nutritional Needs as an Essential Component of Care	13
Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program	13
Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy	13
The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer	13
Ultra-processed food consumption and risk of colorectal cancer precursors: results from 3 prospective cohorts	13
Cardiovascular Disease in Breast Cancer Survivors: An Important Topic in Breast Cancer Survivorship	13
Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort	13
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer	13
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors	12
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions	12
Cancer mortality rates by racial and ethnic groups in the United States, 2018-2020	12
Glyphosate exposure and urinary oxidative stress biomarkers in the Agricultural Health Study	12
Prevalence of Flavored e-Cigarette Use Among Subpopulations of Adults in the United States	12
Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured	12
Common Susceptibility Loci for Male Breast Cancer	12
Risk of Rare Cancers Among Solid Organ Transplant Recipients	12
Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis	12
Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation	12
Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals	12
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management	12
How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention	12
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils	12
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia	12
Incidence of in Situ vs Invasive Melanoma: Testing the “Obligate Precursor” Hypothesis	12
Genomic Testing in Localized Prostate Cancer Can Identify Subsets of African Americans With Aggressive Disease	12
EGFR Amplification in Metastatic Colorectal Cancer	12
Meta-Analysis of Quality of Life in Cancer Patients Treated With Immune Checkpoint Inhibitors	11
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation	11
Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate Cancer	11
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer	11
Interventions to improve outcomes for caregivers of patients with advanced cancer: a meta-analysis	11
Speeding implementation in cancer: The National Cancer Institute’s Implementation Science Centers in Cancer Control	11
Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate Cancer	11
Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men	11
Listening to the Patient Voice Adds Value to Cancer Clinical Trials	11
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival	11
Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men	11
Addressing Social Determinants of Health: Now Is the Time	11